Cancer discovery影响因子
Web《生物标志物研究》(Biomarker Research)是一本以Biochemistry, Genetics and Molecular Biology-Molecular Medicine综合研究为特色的国际期刊。该刊由BMC出版商创刊于2013年,刊期1 issue/year。该刊已被国际重要权威数据库SCIE收录。期刊聚焦Biochemistry, Genetics and Molecular Biology-Molecular Medicine领域的重点研究和前沿进展,及时 ... Web2024年最新影响因子正式揭晓!刚刚,2024年6月28日, Clarivate Analytics(科睿唯安)发布了各大SCI期刊的2024年影响因子。 肿瘤神刊CA仍居榜首,但降幅高达43%,近乎腰 …
Cancer discovery影响因子
Did you know?
WebApr 1, 2024 · About the Journal. Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to epidemiologic studies. The journal also … Read Volume 13 Issue 3 of Cancer Discovery. The incidence of early-onset … The BATTLE Trial: Personalizing Therapy for Lung Cancer. Cancer Discovery’s … Blood Cancer Discovery; Cancer Discovery; Cancer Epidemiology, Biomarkers, & … Cancer is daunting in the breadth and scope of its diversity, spanning genetics, … WebCancer Research Communications is an open access peer-reviewed journal that encompasses the full spectrum of research on cancer. Launched in October 2024, the journal aims to accelerate the pace of discovery and stimulate innovation in cancer science and medicine by providing a venue for rapid open publication of hypotheses, methods, …
WebApr 1, 2024 · About the Journal. Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug sensitivity and resistance; pharmacogenetics and pharmacogenomics; personalized medicine; immunotherapy; … WebFirst Published: 27 March 2024. Herein, we report a fully remote clinical trial of an oral anticancer drug, which is the first of its kind in Japan. This framework is a breakthrough …
Web2024年最新影响因子正式揭晓!刚刚,2024年6月28日, Clarivate Analytics(科睿唯安)发布了各大SCI期刊的2024年影响因子。 肿瘤神刊CA仍居榜首,但降幅高达43%,近乎腰斩! 肿瘤神刊+四大医学杂志2024 JIFCA286.…
WebJun 28, 2024 · 第四类, 基础类顶尖牛刊 ,以 cancer cell , cancer discovery 为代表,这连个期刊是肿瘤基础研究领域中的翘楚,都在 20 分以上,前者是 CELL 的子刊,去年是 27 分,今年发生了一定幅度的下降,但是底蕴犹在,并无大碍,后者是美国肿瘤研究协会( AACR )下的一线 ...
Webblood cancer discov 润色咨询. blood cancer discovery. 出版年份:暂无数据 年文章数:暂无数据 投稿命中率:5.0%. 出版周期:暂无数据 自引率:暂无数据 审稿周期:平均2月 churchill car insurance green flagWeb美国癌症研究学会(AACR)于2024年出版了一份新刊物,Blood Cancer Discovery。作为Cancer Discovery的姊妹刊,Blood Cancer Discovery期刊主要收录在血液系统疾病基础、转化和临床研究等方向具有重大发现及较大影响力的研究内容,旨在推动血液病领域的研究和交流。. 目前,恶性血液病占癌症病例的10%,AACR推出 ... devil went down to georgia lyric videoWeb至于Nature communications,nature给它的定位是介于pnas和nature之间,在线发表一些重大成果,无纸质刊物,基本全是是开源的,一方面也是走现在期刊开源的一个潮流,现在一年发文量也已经达到了5000篇左右。 … churchill car insurance give backWebNov 22, 2024 · Cell Discovery :该刊明年影响因子也会迎来可喜的翻倍,从今年的10.8分,筋斗云似的增长至24.5分。且2024年其发文量迎来小幅度增长,可以窥见杂志社影响力日渐成熟,对“低发文量”的依赖程度在减低。 ... 如Translational Lung Cancer Research、Chinese Journal of Cancer Research ... churchill car insurance green cardhttp://lib.smu.edu.cn/article/detail/144 devil went down to georgia by primusWeb1 OA期刊(开放获取)发文量大. “四大神刊”发文量简直海大,小编找来2015年的数据仅供给大家做个参考:《Medicine》发文1989篇,《Oncotarget》发文3204篇,《Scientific Reports》发文达10642篇, … churchill car insurance helplineWeb《lancet oncology》发布于爱科学网,并永久归类相关sci期刊导航类别中,本站只是硬性分析 "《lancet oncol》" 杂志的可信度。学术期刊真正的价值在于它是否能为科技进步及社会发展带来积极促进作用。"《lancet oncol》" 的价值还取决于各种因素的综合分析。 devil went down to georgia fiddle player